Standards › ASF Health Standards v10 › Standard 53
Standard 53
Allergology
Allergology: allergy history recorded before any exposure, anaphylaxis treated at once, allergen testing quality-controlled and interpreted by a clinician, immunotherapy under a written protocol, and results communicated with a written action plan..
Each criterion is shown in three settings: Humanitarian settings, Transition and fragile, and Standard. In standard settings, every criterion is Must.
Training colours: red means essential, green recommended, yellow optional. Each course shows its level for each setting: humanitarian, transition and fragile, and standard.
53.1Allergy History Is Taken and RecordedHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Every patient has an allergy history taken and recorded before any drug, product or allergen is given, and it is checked at each new prescription and each change of condition.
Why it matters.
How the surveyor verifies this criterion
Sample. Review the allergy history records of a random sample of patients who received a drug or product in the last 3 months.
1. An allergy history is recorded before the first drug or product is given.
Method. Compare the time of the first administration with the time the allergy history was recorded, for each sampled patient.
Evidence to show. Allergy history record (ALR-FRM-001).
Pass when. Every sampled patient has an allergy history recorded before the first administration.
2. The record covers the agent, the reaction and its severity.
Method. Check each sampled allergy entry for the three elements.
Evidence to show. Allergy history record (ALR-FRM-001).
Pass when. Every sampled allergy entry records the agent, the reaction and the severity.
3. The history is checked at each new prescription.
Method. Check the dates of the checks against the dates of new prescriptions for the sample.
Evidence to show. Allergy history record (ALR-FRM-001).
Pass when. Every sampled new prescription has a recorded check of the allergy history.
Immediate fail (any one means the criterion is not met). A patient with a known penicillin reaction is given amoxicillin because the allergy was never recorded.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Allergy history taking and recording (ALR-SOP-001); allergy history record | Must |
| Manager (ISCO 1342) | Checks the criterion at each review | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ALR-SOP-001 · Allergy history taking and recording | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ALR-FRM-001 · Allergy history record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Allergy & Immunotherapy Safety Endorsement (AMB-18) | Manager; Nurse |
References
- WHO (2021). Global Patient Safety Action Plan 2021–2030: Towards Eliminating Avoidable Harm in Health Care. Used for: Allergy history and medication safety https://news.gmj.ge/guideline/global-patient-safety-action-plan-2021-2030-towards-eliminating-avoidable-harm-in-health-care/
53.2Anaphylaxis Is Recognised and Treated at OnceHumanitarian settings: MinimumTransition and fragile: MustStandard: Must
Anaphylaxis is recognised from its early signs and treated at once with adrenaline under a written protocol. Adrenaline and the emergency kit are stocked, checked and in date, and each episode is recorded.
Why it matters.
How the surveyor verifies this criterion
Sample. Review every anaphylaxis episode in the last 12 months, and the daily kit checks for the same period.
1. Anaphylaxis is treated at once with adrenaline under the written protocol.
Method. Check each recorded episode for the time of recognition and the time of the first adrenaline dose.
Evidence to show. Anaphylaxis recognition and treatment (ALR-SOP-002).
Pass when. Every recorded episode has adrenaline given at once, or a recorded reason.
2. Adrenaline and the emergency kit are stocked, checked and in date.
Method. Check the daily record and the expiry dates for the sample period.
Evidence to show. Anaphylaxis episode and adrenaline check register (ALR-REG-001).
Pass when. Every daily check is recorded, and the adrenaline is in date on every check.
Immediate fail (any one means the criterion is not met). A patient in clinic develops anaphylaxis, and the adrenaline in the kit expired four months earlier.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Anaphylaxis recognition and treatment (ALR-SOP-002); anaphylaxis and emergency response in procedure units | Must |
| Secretary (ISCO 3344) | Keeps the Anaphylaxis episode and adrenaline check register (ALR-REG-001); resuscitation area readiness | Must |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ALR-SOP-002 · Anaphylaxis recognition and treatment | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ALR-REG-001 · Anaphylaxis episode and adrenaline check register | Secretary (ISCO 3344) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Allergy & Immunotherapy Safety Endorsement (AMB-18) | Manager; Nurse |
References
- Resuscitation Council UK (n.d.). Emergency treatment of anaphylaxis: guidelines for healthcare providers. Used for: Emergency treatment of anaphylaxis with adrenaline https://news.gmj.ge/guideline/emergency-treatment-of-anaphylaxis-guidelines-for-healthcare-providers/
- WHO (2021). Brief overview of anaphylaxis as an adverse event following immunization (AEFI) and practical guidance on its identification, case management and response in a primary care setting. Used for: Anaphylaxis recognition and reporting https://news.gmj.ge/guideline/brief-overview-of-anaphylaxis-as-an-adverse-event-following-immunization-aefi-and-practical-guidance-on-its-identification-case-management-and-response-in-a-primary-care-setting/
53.3Allergen Testing Is Quality-Controlled and Interpreted by a ClinicianHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Skin and blood allergy tests use validated methods with controls checked before results are reported. Results are interpreted by a qualified clinician with the clinical history and reported with their limits.
Why it matters.
How the surveyor verifies this criterion
Sample. Review the quality control and result records for the sample period, and the external assessment results.
1. Results are interpreted by a qualified clinician with the clinical history.
Method. Check each sampled result for the interpretation and the signing clinician.
Evidence to show. Allergy test result and interpretation record (ALR-FRM-002).
Pass when. Every sampled result has a clinician interpretation that uses the clinical history.
Immediate fail (any one means the criterion is not met). A skin test run with a failed positive control is reported, and a patient is wrongly told they are not allergic.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Nurse (ISCO 2221) | Completes the Allergy test result and interpretation record | Medium |
| Manager (ISCO 1342) | Checks the criterion at each review | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ALR-SOP-003 · Allergen testing quality control and interpretation | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ALR-FRM-002 · Allergy test result and interpretation record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Allergy & Immunotherapy Safety Endorsement (AMB-18) | Manager; Nurse |
References
- The skin prick test – European standards (Clinical and Translational Allergy (Heinzerling L et al.), 2013)
53.4Allergen Immunotherapy Follows a Written ProtocolHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Allergen immunotherapy starts only after the written eligibility criteria are met and consent is recorded. Each dose follows the written escalation, with observation after each dose and emergency equipment at hand.
Why it matters.
How the surveyor verifies this criterion
Sample. Review all immunotherapy patients in the last 12 months, with their eligibility, consent and dose records.
1. Immunotherapy starts only after the written eligibility criteria are met.
Method. Check each sampled patient for the eligibility record before the first dose.
Evidence to show. Allergen immunotherapy protocol (ALR-POL-001).
Pass when. Every sampled patient met the criteria before the first dose.
2. Each dose follows the escalation with observation time and emergency equipment.
Method. Check the dose and observation records for a sample of doses.
Evidence to show. Immunotherapy dose and observation record (ALR-FRM-003).
Pass when. Every sampled dose follows the schedule, with observation time recorded and equipment available.
Immediate fail (any one means the criterion is not met). A patient receives a dose above the schedule and is discharged after 5 minutes of observation.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Allergen immunotherapy protocol | Medium |
| Nurse (ISCO 2221) | Completes the Immunotherapy dose and observation record | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ALR-FRM-003 · Immunotherapy dose and observation record | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
| ALR-POL-001 · Allergen immunotherapy protocol | Chief executive (ISCO 1120) | Governing body members | N/A | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Allergy & Immunotherapy Safety Endorsement (AMB-18) | Manager; Nurse |
References
- EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis (European Academy of Allergy and Clinical Immunology (EAACI) (Roberts G et al.), 2018)
53.5Allergy Results Are Communicated and Acted OnHumanitarian settings: MinimumTransition and fragile: MediumStandard: Must
Each allergy result and its advice is communicated to the patient and referrer. Each patient has a written action plan, and the allergy alert on the record is updated when a result changes the allergy history.
Why it matters.
How the surveyor verifies this criterion
Sample. Review allergy results and action plans for a sample of patients in the last 6 months, and the allergy alerts on their records.
1. Each result and its advice is communicated to the patient and the referrer.
Method. Check each sampled result for the record of communication.
Evidence to show. Allergy results communication and action plan (ALR-SOP-004).
Pass when. Every sampled result has a recorded communication to the patient and the referrer.
2. Each patient has a written action plan.
Method. Check each sampled patient for the action plan.
Evidence to show. Allergy action plan (ALR-FRM-004).
Pass when. Every sampled patient has a written action plan.
3. The allergy alert is updated when a result changes the history.
Method. Check each sampled result that changed the history against the alert on the record.
Evidence to show. Allergy history record (ALR-FRM-001).
Pass when. Every changed history has an updated alert on the record.
Immediate fail (any one means the criterion is not met). A new allergy is confirmed by testing, but the alert on the record is never updated.
Staff responsible
| Role | Responsibility | Level |
|---|---|---|
| Manager (ISCO 1342) | Maintains the Allergy results communication and action plan (ALR-SOP-004); critical result reporting | Medium |
| Nurse (ISCO 2221) | Completes the Allergy action plan | Medium |
Documents: who does each step
| Document | Writes | Approves | Fills in | Checks and signs | Files and uploads |
|---|---|---|---|---|---|
| ALR-SOP-004 · Allergy results communication and action plan | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) |
| ALR-FRM-004 · Allergy action plan | Manager (ISCO 1342) | Chief executive (ISCO 1120) | Secretary (ISCO 3344) | Manager (ISCO 1342) | Secretary (ISCO 3344) |
E-learning: who must take each course
| Course | Who must take it |
|---|---|
| Allergy & Immunotherapy Safety Endorsement (AMB-18) | Manager; Nurse |
References
- WHO (2021). Global Patient Safety Action Plan 2021–2030: Towards Eliminating Avoidable Harm in Health Care. Used for: Communication of safety information to patients https://news.gmj.ge/guideline/global-patient-safety-action-plan-2021-2030-towards-eliminating-avoidable-harm-in-health-care/
Who is responsible for Standard 53
Each criterion names the positions responsible for it. Every position links to its own terms of reference.
| Criterion | Responsible | Supports |
|---|---|---|
| 53.1 Allergy History Is Taken and Recorded | Consultant physician (internal medicine) Head nurse / ward manager |
Emergency nurse |
| 53.2 Anaphylaxis Is Recognised and Treated at Once | Emergency nurse Emergency physician |
Anaesthesiologist |
| 53.3 Allergen Testing Is Quality-Controlled and Interpreted by a Clinician | Head of laboratory Medical laboratory scientist |
Consultant physician (internal medicine) |
| 53.4 Allergen Immunotherapy Follows a Written Protocol | Consultant physician (internal medicine) Head nurse / ward manager |
Emergency nurse |
| 53.5 Allergy Results Are Communicated and Acted On | Head of laboratory Consultant physician (internal medicine) |
Medical laboratory scientist |
Role details: reporting, supervision and training
Training shown is the general recommendation. Role-specific training is set in the next improvement round.
Questions and answers
The criterion text is the authority. These answers summarise it.
Who does Standard 60 apply to?
Services that take allergy histories, test for allergies, give allergen immunotherapy or treat allergic reactions, including clinics and hospital wards.
What do the colours mean for this standard?
Red (Must) is required. Green (Medium) is recommended. Yellow (Minimum) is the lowest acceptable level in humanitarian settings. Standard setting is Must on every criterion.
Is the allergy history taken before treatment?
Yes. Under 53.1 every patient has an allergy history recorded before any drug, product or allergen is given, and it is checked at each new prescription.
How is anaphylaxis treated?
Under 53.2 anaphylaxis is recognised from its early signs and treated at once with adrenaline under a written protocol, and the emergency kit is stocked and in date.
Are allergy tests checked?
Under 53.3 allergy tests use validated methods with controls checked first, and results are interpreted by a qualified clinician.
Is immunotherapy given under a protocol?
Under 53.4 immunotherapy starts only when eligibility criteria are met and consent is recorded, and each dose follows a written escalation with observation after it.
Are allergy results communicated?
Yes. Under 53.5 each result and its advice reach the patient and referrer, each patient has a written action plan, and the allergy alert on the record is updated.
Guidelines for this standard
8 guideline(s) are held in the GMJ Guidelines Library and listed here. Each link opens the full guideline on news.gmj.ge. The complete library, grouped by standard, is at Guidelines.
- The skin prick test – European standards (GA2LEN)
- EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis (EAACI)
- Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update (World Allergy Organization)
- The Skin Prick Test – European Standards (EAACI) (European Academy of Allergy and Clinical Immunology)
- Emergency treatment of anaphylaxis: guidelines for healthcare providers (Resuscitation Council UK)
- Brief overview of anaphylaxis as an adverse event following immunization (AEFI) and practical guidance on its identification, case management and response in a primary care setting (World Health Organization)
- Guidelines for healthcare workers on the proper interpretation of vaccine vial monitors and their use (Pan American Health Organization)
- Protocol for the Use of the Performance Monitoring Tool for the National Expanded Program on Immunization (Pan American Health Organization)